Silver polyvinyl pyrrolidone nanoparticles exhibit a capsular polysaccharide influenced bactericidal effect against Streptococcus pneumoniae

Frontiers in Microbiology

Volumn 5, Issue DEC, 2014, Pages

  Bibbs, Ronda K ^a   Harris, Rhonda D ^a   Peoples, Veolanda A ^a   Barnett, Cleon ^a   Singh, Shree R ^a   Dennis, Vida A ^a   Coats, Mamie T ^a  

^a ALABAMA STATE UNIVERSITY   (United States)

Author keywords

AgPVP; Antimicrobial; Nanoparticle; Pneumococcus; Serotype; Titanium dioxide

Indexed keywords

GOLD; METAL ION; NANOPARTICLE; NANOSPHERE; POLYSACCHARIDE; POVIDONE; SILVER; TITANIUM DIOXIDE;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CAPSULE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIOLYSIS; BACTERIUM CULTURE; CELL DAMAGE; EXPOSURE; INFRARED SPECTROSCOPY; MINIMUM BACTERICIDAL CONCENTRATION; MUTANT; NONHUMAN; OPTICAL DENSITY; PARAMETERS; SCANNING ELECTRON MICROSCOPY; SEROTYPE; SPECTROSCOPY; STREPTOCOCCUS PNEUMONIAE; TRANSMISSION ELECTRON MICROSCOPY; WAVELENGTH;

STREPTOCOCCUS PNEUMONIAE;

EID: 84920680406     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00665     Document Type: Article

References (57)

1. Abdelnour, A., Soley, C., Guevara, S., Porat, N., Dagan, R., and Arguedas, A. (2009). Streptococcus pneumoniae serotype 3 among Costa Rican children with otitis media: clinical, epidemiological characteristics and antimicrobial resistance patterns. BMC Pediatr. 9:52. doi: 10.1186/1471-2431-9-52
2. Ahamed, M., Alsalhi, M. S., and Siddiqui, M. K. (2010). Silver nanoparticle applications and human health. Clin. Chim. Acta 411, 1841-1848. doi: 10.1016/j.cca.2010.08.016
3. Ahmad, T., Wani, I. A., Manzoor, N., Ahmed, J., and Asiri, A. M. (2013). Biosynthesis, structural characterization and antimicrobial activity of gold and silver nanoparticles. Colloids Surf. B Biointerfaces 107, 227-234. doi: 10.1016/j.colsurfb.2013.02.004
4. Arshi, N., Ahmed, F., Kumar, S., Anwar, M. S., Koo, B. H., and Lee, C. G. (2011). Comparative study of the Ag/PVP nanocomposites synthesized in water and in ethylene glycol. Curr. Appl. Phys. 11(Suppl. 1), S346-S349. doi: 10.1016/j.cap.2010.11.045
5. Asharani, P. V., Lianwu, Y., Gong, Z., and Valiyaveettil, S. (2011). Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology 5, 43-54. doi: 10.3109/17435390.2010.489207
6. Barnett, C., Bell, C., Vig, K., Akpovo, A. C., Johnson, L., Pillai, S.,et al. (2011). Development of a LIBS assay for the detection of Salmonella enterica serovar Typhimurium from food. Anal. Bioanal. Chem. 400, 3323-3330. doi: 10.1007/s00216-011-4844-3
7. Beer, C., Foldbjerg, R., Hayashi, Y., Sutherland, D. S., and Autrup, H. (2012). Toxicity of silver nanoparticles - nanoparticle or silver ion? Toxicol. Lett. 208, 286-292. doi: 10.1016/j.toxlet.2011.11.002
8. Bryce, J., Boschi-Pinto, C., Shibuya, K., Black, R. E., and WHO Child Health Epidemiology Reference Group. (2005). WHO estimates of the causes of death in children. Lancet 365, 1147-1152. doi: 10.1016/S0140-6736(05)71877-8
9. Calix, J. J., Dagan, R., Pelton, S. I., Porat, N., and Nahm, M. H. (2012). Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution. Clin. Infect. Dis. 54, 794-799. doi: 10.1093/cid/cir953
10. CDC. (2013). Streptococcus pneumoniae. Active Bacterial Core Surveillance Report, Emerging infections Program Network. Atlanta: Centers for Disease Control and Prevention.
11. Coats, M. T., Murphy, T., Paton, J. C., Gray, B., and Briles, D. E. (2011). Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A. Microb. Pathog. 50, 343-349. doi: 10.1016/j.micpath.2011.02.010
12. Daka, D., Loha, E., and Giday, A. (2011). Streptococcus pneumoniae and antimicrobial resistance, hawassa referral hospital, South Ethiopia. J. Med. Lab. Diagn. 2, 27-30.
13. Devika, R., Elumalai, S., Manikandan, E., and Eswaramoorthy, D. (2012). Biosynthesis of silver nanoparticles using the fungus Pleurotus ostreatus and their antibacterial activity. Sci. Rep. 1:557 doi: 10.4172/scientificreports.557
14. El-Nour, K. M. M. A., Eftaiha, A., Al-Warthan, A., and Ammar, R. A. A. (2010). Synthesis and applications of silver nanoparticles. Arabian J. Chem. 3, 135-140. doi: 10.1016/j.arabjc.2010.04.008
15. Ghasemi, A., Namaki, S., and Mirshafiey, A. (2009). Streptococcus pneumoniae. J. Chinese Clin. Med. 4(Suppl.), 1-8.
16. Ghosh, P., Han, G., De, M., Kim, C. K., and Rotello, V. M. (2008). Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 60, 1307-1315. doi: 10.1016/j.addr.2008.03.016
17. Gnanadhas, D. P., Ben Thomas, M., Thomas, R., Raichur, A. M., and Chakravortty, D. (2013). Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo. Antimicrob. Agents Chemother. 57, 4945-4955. doi: 10.1128/AAC.00152-13
18. Hamilton, R. F., Buckingham, S., and Holian, A. (2014). The effect of size on Ag nanosphere toxicity in macrophage cell models and lung epithelial cell lines is dependent on particle dissolution. Int. J. Mol. Sci. 15, 6815-6830. doi: 10.3390/ijms15046815
19. Hammerschmidt, S., Wolff, S., Hocke, A., Rosseau, S., Müller, E., and Rohde, M. (2005). Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect. Immun. 73, 4653-4667. doi: 10.1128/IAI.73.8.4653-4667.2005
20. Hathaway, L. J., Brugger, S. D., Morand, B., Bangert, M., Rotzetter, J. U., Hauser, C.,et al. (2012). Capsule type of Streptococcus pneumoniae determines growth phenotype. PLoS Pathog. 8:e1002574. doi: 10.1371/journal.ppat.1002574
21. Hotomi, M., Togawa, A., Kono, M., Ikeda, Y., Takei, S., Hollingshead, S. K.,et al. (2013). PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan. PLoS ONE 8:e58124. doi: 10.1371/journal.pone.0058124
22. Huang, C. N., Bow, J. S., Zheng, Y., Chen, S. Y., Ho, N., and Shen, P. (2010). Nonstoichiometric titanium oxides via pulsed laser ablation in water. Nanoscale Res. Lett. 5, 972-985. doi: 10.1007/s11671-010-9591-4
23. Hyams, C., Camberlein, E., Cohen, J. M., Bax, K., and Brown, J. S. (2010). The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect. Immun. 78, 704-715. doi: 10.1128/IAI.00881-09
24. Ivask, A., George, S., Bondarenko, O., and Kahru, A. (2012). "Metal-containing nano-antimicrobials: differentiating the impact of solubilized metals and particles," in Nano-Antimicrobials: Progress and Prospects, eds N. Cioffiand M. Rai (Berlin: Springer), 253-290.
25. Johnston, J. W., Briles, D. E., Myers, L. E., and Hollingshead, S. K. (2006). Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence. Infect. Immun. 74, 1171-1180. doi: 10.1128/IAI.74.2.1171-1180.2006
26. Kaittanis, C., Santra, S., and Perez, J. M. (2010). Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. Adv. Drug Deliv. Rev. 62, 408-423. doi: 10.1016/j.addr.2009.11.013
27. Kimling, J., Maier, M., Okenve, B., Kotaidis, V., Ballot, H., and Plech, A. (2006). Turkevich method for gold nanoparticle synthesis revisited. J. Phys. Chem. B 110, 15700-15707. doi: 10.1021/jp061667w
28. Kuhn, K. P., Chaberny, I. F., Massholder, K., Stickler, M., Benz, V. W., Sonntag, H. G.,et al. (2003). Disinfection of surfaces by photocatalytic oxidation with titanium dioxide and UVA light. Chemosphere 53, 71-77. doi: 10.1016/S0045-6535(03)00362-X
29. Li, J., Szalai, A. J., Hollingshead, S. K., Nahm, M. H., and Briles, D. E. (2009). Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages. Infect. Immun. 77, 464-471. doi: 10.1128/IAI.00892-08
30. Lima, E., Guerra, R., Lara, V., and Guzmán, A. (2013). Gold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhi. Chem. Cent. J. 7, 11. doi: 10.1186/1752-153X-7-11
31. Losasso, C., Belluco, S., Cibin, V., Zavagnin, P., Mičetić, I., Gallocchio, F.,et al. (2014). Antibacterial activity of silver nanoparticles: sensitivity of different Salmonella serovars. Front. Microbiol. 5:227. doi: 10.3389/fmicb.2014.00227
32. Magee, A. D., and Yother, J. (2001). Requirement for capsule in colonization by Streptococcus pneumoniae. Infect. Immun. 69, 3755-3761. doi: 10.1128/IAI.69.6.3755-3761.2001
33. Marks, L. R., Davidson, B. A., Knight, P. R., and Hakansson, A. P. (2013). Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. MBio 4, e00438-13. doi: 10.1128/mBio.00438-13
34. Marks, L. R., Reddinger, R. M., and Hakansson, A. P. (2012). High levels of genetic recombination during nasopharyngeal carriage and biofilm formation in Streptococcus pneumoniae. MBio 3, e00200-12. doi: 10.1128/mBio.00200-12
35. Mehr, S., and Wood, N. (2012). Streptococcus pneumoniae-a review of carriage, infection, serotype replacement and vaccination. Paediatr. Respir. Rev. 13, 258-264. doi: 10.1016/j.prrv.2011.12.001
36. Melin, M., Trzcinski, K., Meri, S., Käyhty, H., and Väkeväinen, M. (2010). The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect. Immun. 78, 5262-5270. doi: 10.1128/IAI.00740-10
37. Morona, J. K., Miller, D. C., Morona, R., and Paton, J. C. (2004). The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae. J. Infect. Dis. 189, 1905-1913. doi: 10.1086/383352
38. Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., Ramírez, J. T.,et al. (2005). The bactericidal effect of silver nanoparticles. Nanotechnology 16, 2346-2353. doi: 10.1088/0957-4484/16/10/059
39. Murkerji, R., Mirza, S., Roche, A. M., Widener, R. W., Croney, C. M., Rhee, D. K.,et al. (2012). Pneumoccal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. J. Immunol. 189, 5327-5335. doi: 10.4049/jimmunol.1201967
40. Okade, H., Funatsu, T., Eto, M., Furuya, Y., Mizunaga, S., Nomura, N.,et al. (2014). Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period. J. Infect. Chemother. 20, 423-428. doi: 10.1016/j.jiac.2014.03.010
41. Pelgrift, R. Y., and Friedman, A. J. (2013). Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 65, 1803-1815. doi: 10.1016/j.addr.2013.07.011
42. Rai, M., Yadav, A., and Gade, A. (2009). Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 27, 76-83. doi: 10.1016/j.biotechadv.2008.09.002
43. Ravishankar, R., and Jamuna, B. (2011). "Nanoparticles and their potential application as antimicrobials," in Science Against Microbial Pathogens: Communicating Current Research and Technological Advances, ed. A. Mendez-Vilas (Extremadura: Formatex Research Center), 197-209.
44. Ren, B., Li, J., Genschmer, K., Hollingshead, S. K., and Briles, D. E. (2012). The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro. Clin. Vaccine Immunol. 19, 1574-1582. doi: 10.1128/CVI.00393-12
45. Sadeghi, B., Jamal, I. M., Kia, S., Amini, A., and Ghafari, S. (2010). Synthesis and characterization of silver nanoparticles for antibacterial activity. Int. J. Nano. Dim. 1, 76-83.
46. Sahayaraj, K., and Rajesh, S. (2011). Bionanoparticles: Synthesis and Antimicrobial Applications. Badajoz: Formatex Research Center.
47. Sanders, M. E., Norcross, E. W., Robertson, Z. M., Moore, Q. C. III, Fratkin, J., and Marquart, M. E. (2011). The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis. Invest. Ophthalmol. Vis. Sci. 52, 865-872. doi: 10.1167/iovs.10-5513
48. Seil, J. T., and Webster, T. J. (2012). Antimicrobial applications of nanotechnology: methods and literature. Int. J. Nanomedicine 7, 2767-2781. doi: 10.2147/IJN.S24805
49. Sun, X., Sheng, Z., and Liu, Y. (2013). Effects of silver nanoparticles on microbial community structure in activated sludge. Sci. Total Environ. 443, 828-835. doi: 10.1016/j.scitotenv.2012.11.019
50. Temime, L., Boelle, P. Y., Opatowski, L., and Guillemot, D. (2008). Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population. PLoS ONE 3:e3244. doi: 10.1371/journal.pone.0003244
51. Tiwari, P., Vig, K., Dennis, V. A., and Singh, S. R. (2011). Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 1, 31-63. doi: 10.3390/nano1010031
52. Weinberger, D. M., Trzcinski, K., Lu, Y. J., Bogaert, D., Brandes, A., Galagan, J.,et al. (2009). Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 5:e1000476. doi: 10.1371/journal.ppat.1000476
53. Wyres, K. L., Lambertsen, L. M., Croucher, N. J., McGee, L., von Gottberg, A., Liñares, J.,et al. (2012). Pneumococcal capsular switching: a historical perspective. J. Infect. Dis. 207, 439-449. doi: 10.1093/infdis/jis703
54. Yadav, M. K., Park, S. W., Chae, S. W., Song, J. J., and Kim, H. C. (2013). Antimicrobial activities of Eugenia caryophyllata extract and its major chemical constituent eugenol against Streptococcus pneumoniae. APMIS 121, 1198-1206. doi: 10.1111/apm.12067
55. You, C., Han, C., Wang, X., Zheng, Y., Li, Q., Hu, X.,et al. (2012). The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol. Biol. Rep. 39, 9193-9201. doi: 10.1007/s11033-012-1792-8
56. Zemlickova, H., Urbaskova, P., Adámková, V., Motlová, J., Lebedová, V., and Procházka, B. (2006). Characteristics of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus isolated from the nasopharynx of healthy children attending day-care centres in the Czech Republic. Epidemiol. Infect. 134, 1179-1187. doi: 10.1017/S0950268806006157
57. Zhou, Y., Kong, Y., Kundu, S., Cirillo, J. D., and Liang, H. (2012). Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guerin. J. Nanobiotechnol. 10, 19. doi: 10.1186/1477-3155-10-19